Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 770

1.

Implementation of a mobile inpatient quality of life (QoL) assessment for oncology nursing.

Schuler MK, Trautmann F, Radloff M, Schmädig R, Hentschel L, Eberlein-Gonska M, Petzold T, Vetter H, Oberlack S, Ehninger G, Schmitt J.

Support Care Cancer. 2016 Aug;24(8):3391-9. doi: 10.1007/s00520-016-3163-9. Epub 2016 Mar 16.

PMID:
26984243
2.

How should I treat dislocation of a TAVI SAPIEN prosthesis into the left ventricle?

Tiroch K, Schleiting H, Karpettas N, Schmitz E, Vetter HO, Seyfarth M, Vorpahl M, Thomas M, Abdel-Wahab M, Sier H, Richardt G.

EuroIntervention. 2015 Mar;10(11):1370-2. doi: 10.4244/EIJY14M09_04.

3.

"First-in-man" MitraClip via pulmonary vein access through a right mini-thoracotomy in a patient with agenesis of the inferior vena cava.

Tiroch K, Brinkmann H, Koudonas D, Vorpahl M, Seyfarth M, Vetter HO.

EuroIntervention. 2015 Feb;10(10):1204-7. doi: 10.4244/EIJY14M05_04.

4.

Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: a prospective study with the LiMAx test.

Kaffarnik MF, Lock JF, Vetter H, Ahmadi N, Lojewski C, Malinowski M, Neuhaus P, Stockmann M.

Crit Care. 2013 Oct 31;17(5):R259. doi: 10.1186/cc13089.

5.

Drug development from natural products: exploiting synergistic effects.

Ulrich-Merzenich G, Panek D, Zeitler H, Vetter H, Wagner H.

Indian J Exp Biol. 2010 Mar;48(3):208-19. Review.

PMID:
21046973
6.

Spine trauma due to diving: main features and short-term neurological outcome.

Amorim EC, Vetter H, Mascarenhas LB, Gomes EG, Carvalho JB, Gomes JF.

Spinal Cord. 2011 Feb;49(2):206-10. doi: 10.1038/sc.2010.79. Epub 2010 Jul 13.

PMID:
20625383
7.

Bolus ingestion of white and green tea increases the concentration of several flavan-3-ols in plasma, but does not affect markers of oxidative stress in healthy non-smokers.

Müller N, Ellinger S, Alteheld B, Ulrich-Merzenich G, Berthold HK, Vetter H, Stehle P.

Mol Nutr Food Res. 2010 Nov;54(11):1636-45. doi: 10.1002/mnfr.200900390.

PMID:
20540144
8.

[Parameters of quality for aortic valve replacement].

Vetter HO, Driever R, Schmitz E.

Dtsch Med Wochenschr. 2009 Oct;134 Suppl 6:S203-5. doi: 10.1055/s-0029-1241910. Epub 2009 Oct 15. German.

PMID:
19834842
9.

New perspectives for synergy research with the "omic"-technologies.

Ulrich-Merzenich G, Panek D, Zeitler H, Wagner H, Vetter H.

Phytomedicine. 2009 Jun;16(6-7):495-508. doi: 10.1016/j.phymed.2009.04.001. Review.

PMID:
19428231
10.

Synergy research: vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling.

Ulrich-Merzenich G, Zeitler H, Vetter H, Kraft K.

Phytomedicine. 2009 Jan;16(1):2-16. doi: 10.1016/j.phymed.2008.11.007. Epub 2008 Dec 31. Review.

PMID:
19118991
11.

Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair.

Harth V, Schafer M, Abel J, Maintz L, Neuhaus T, Besuden M, Primke R, Wilkesmann A, Thier R, Vetter H, Ko YD, Bruning T, Bolt HM, Ickstadt K.

J Toxicol Environ Health A. 2008;71(13-14):887-97. doi: 10.1080/15287390801988160.

PMID:
18569591
12.

Statistical methods for detecting genetic interactions: a head and neck squamous-cell cancer study.

Ickstadt K, Schäfer M, Fritsch A, Schwender H, Abel J, Bolt HM, Brüning T, Ko YD, Vetter H, Harth V.

J Toxicol Environ Health A. 2008;71(11-12):803-15. doi: 10.1080/15287390801985745.

PMID:
18569579
13.

Multiple benign symmetric lipomatosis--a differential diagnosis of obesity. Is there a rationale for fibrate treatment?

Zeitler H, Ulrich-Merzenich G, Richter DF, Vetter H, Walger P.

Obes Surg. 2008 Oct;18(10):1354-6. doi: 10.1007/s11695-008-9491-1. Epub 2008 Jun 5.

PMID:
18528737
14.

Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells.

Seidel MF, Fiebich BL, Ulrich-Merzenich G, Candelario-Jalil E, Koch FW, Vetter H.

Rheumatol Int. 2008 Aug;28(10):1017-22. doi: 10.1007/s00296-008-0564-1. Epub 2008 Mar 27.

PMID:
18368410
15.

Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: new evidence for beneficial anti-inflammatory potency of ETB-receptor antagonism.

Juergens UR, Racké K, Uen S, Haag S, Lamyel F, Stöber M, Gillissen A, Novak N, Vetter H.

Pulm Pharmacol Ther. 2008;21(3):533-9. doi: 10.1016/j.pupt.2007.12.005. Epub 2008 Jan 19.

PMID:
18295521
16.

Multiple benign symmetric lipomatosis--a differential diagnosis of obesity: is there a rationale for fibrate treatment?

Heike Z, Gudrun UM, Frank RD, Vetter H, Walger P.

Obes Surg. 2008 Feb;18(2):240-2. doi: 10.1007/s11695-007-9247-3. Epub 2008 Jan 4.

PMID:
18175197
17.

Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins.

Ulrich-Merzenich G, Zeitler H, Vetter H, Bhonde RR.

Eur J Nutr. 2007 Dec;46(8):431-8. Epub 2007 Oct 26.

PMID:
17965904
18.

Effect of medical honey on wounds colonised or infected with MRSA.

Blaser G, Santos K, Bode U, Vetter H, Simon A.

J Wound Care. 2007 Sep;16(8):325-8.

PMID:
17927079
19.

A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomal-dominant inherited congenital heart disease.

Pabst S, Wollnik B, Rohmann E, Hintz Y, Glänzer K, Vetter H, Nickenig G, Grohé C.

Clin Res Cardiol. 2008 Jan;97(1):39-42. Epub 2007 Sep 25.

PMID:
17891520
20.

Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome.

Seidel MF, Domene AB, Vetter H.

Eur J Clin Microbiol Infect Dis. 2007 Sep;26(9):611-7.

PMID:
17605053
21.

Epidermal growth factor stimulates Rac1 and p21-activated kinase in vascular smooth muscle cells.

Beier I, Düsing R, Vetter H, Schmitz U.

Atherosclerosis. 2008 Jan;196(1):92-7. Epub 2007 Mar 9.

PMID:
17350025
22.

Vitamin C promotes human endothelial cell growth via the ERK-signaling pathway.

Ulrich-Merzenich G, Zeitler H, Panek D, Bokemeyer D, Vetter H.

Eur J Nutr. 2007 Mar;46(2):87-94.

PMID:
17225921
23.

[Effect of candesartan cilexetil with hydrochlorothiazide on blood pressure and ST-segment depression in patients with arterial hypertension].

Uen S, Un I, Fimmers R, Vetter H, Mengden T.

Dtsch Med Wochenschr. 2007 Jan 19;132(3):81-6. German.

PMID:
17219340
24.

Application of the "-Omic-" technologies in phytomedicine.

Ulrich-Merzenich G, Zeitler H, Jobst D, Panek D, Vetter H, Wagner H.

Phytomedicine. 2007 Jan;14(1):70-82. Review.

PMID:
17188482
26.

Systemic stress hormone response in patients undergoing open heart surgery with or without cardiopulmonary bypass.

Hoda MR, El-Achkar H, Schmitz E, Scheffold T, Vetter HO, De Simone R.

Ann Thorac Surg. 2006 Dec;82(6):2179-86.

PMID:
17126131
27.

New evidence of H1-receptor independent COX-2 inhibition by fexofenadine HCl in vitro.

Juergens UR, Gillissen A, Uen S, Racké K, Stöber M, Darlath W, Vetter H.

Pharmacology. 2006;78(3):129-35. Epub 2006 Oct 2.

PMID:
17016062
28.

Pulse wave velocity is increased in patients with transient myocardial ischemia.

Baulmann J, Homsi R, Uen S, Düsing R, Fimmers R, Vetter H, Mengden T.

J Hypertens. 2006 Oct;24(10):2085-90.

PMID:
16957570
30.

Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis.

Zeitler H, Ulrich-Merzenich G, Hoffmann L, Kornblum C, Schmidt S, Vetter H, Walger P.

Artif Organs. 2006 Aug;30(8):597-605.

PMID:
16911313
31.
32.

Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach.

Stier S, Neuhaus T, Albers P, Wernert N, Grünewald E, Forkert R, Vetter H, Ko Y.

Arch Toxicol. 2006 Oct;80(10):713-8. Epub 2006 May 24.

PMID:
16721595
33.

BTNL2 gene variant and sarcoidosis.

Li Y, Wollnik B, Pabst S, Lennarz M, Rohmann E, Gillissen A, Vetter H, Grohé C.

Thorax. 2006 Mar;61(3):273-4. No abstract available.

34.

Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis.

Pabst S, Baumgarten G, Stremmel A, Lennarz M, Knüfermann P, Gillissen A, Vetter H, Grohé C.

Clin Exp Immunol. 2006 Mar;143(3):420-6.

35.

[The modified Bonn Malmö protocol (MBMP) in the treatment of acquired haemophilia A].

Zeitler H, Ulrich-Merzenich G, Walger P, Düsing R, Vetter H, Brackmann HH.

Dtsch Med Wochenschr. 2006 Jan 27;131(4):141-7. German.

PMID:
16429335
36.

Macrophage-like synoviocytes display phenotypic polymorphisms in a serum-free tissue-culture medium.

Seidel MF, Koch FW, Vetter H.

Rheumatol Int. 2006 Jan;26(3):244-51. Epub 2004 Dec 10.

PMID:
16365755
37.

Differential effects of fexofenadine on arachidonic acid metabolism in cultured human monocytes.

Juergens UR, Darlath W, Stober M, Racké K, Tasci S, Gillissen A, Vetter H.

Pharmacology. 2006;76(1):40-5. Epub 2005 Oct 26.

PMID:
16254456
38.

Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.

Stier S, Koll C, Neuhaus T, Fronhoffs S, Forkert R, Tuohimaa A, Vetter H, Ko Y.

Anticancer Drugs. 2005 Nov;16(10):1115-21.

PMID:
16222154
39.

Identification of p54(nrb) and the 14-3-3 Protein HS1 as TNF-alpha-inducible genes related to cell cycle control and apoptosis in human arterial endothelial cells.

Stier S, Totzke G, Gruewald E, Neuhaus T, Fronhoffs S, Schoneborn S, Vetter H, Ko Y.

J Biochem Mol Biol. 2005 Jul 31;38(4):447-56.

PMID:
16053712
40.

[Small cell bronchial carcinoma. Main symptoms: cough, hemoptysis, hoarseness, dyspnea, paraneoplastic syndrome., weight loss, neurologic manifestations and post-stenotic pneumonia].

Pabst S, Stier S, Vetter H, Grohé C.

Praxis (Bern 1994). 2005 May 18;94(20):803-9; quiz 810. German. No abstract available.

PMID:
15957614
41.

Platelet activation markers in patients with heart assist device.

Dewald O, Schmitz C, Diem H, Goehring P, Vetter HO, Roell W, Goedje O, Tschoepe D, Reichart B.

Artif Organs. 2005 Apr;29(4):292-9.

PMID:
15787623
42.
43.

A novel component of the ubiquitin pathway, ubiquitin carboxyl extension protein 1 is overexpressed in prostate cancer.

Ko Y, Hahn T, Lu H, Ma ZL, Chen J, Rothe M, Florin A, Fronhoffs S, Albers P, Sachinidis A, Vetter H, Kaminski A, Behrens P, Wellmann A, Wernert N.

Int J Mol Med. 2005 Feb;15(2):183-96.

PMID:
15647830
44.

[Non-small-cell lung carcinoma].

Pabst S, Stier S, Vetter H, Grohé Ch.

Praxis (Bern 1994). 2004 Dec 8;93(50):2085-92. German. No abstract available.

PMID:
15646675
45.

Telemonitoring of blood pressure self measurement in the OLMETEL study.

Mengden T, Ewald S, Kaufmann S, vor dem Esche J, Uen S, Vetter H.

Blood Press Monit. 2004 Dec;9(6):321-5. Review.

PMID:
15564988
46.

Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept.

Zeitler H, Ulrich-Merzenich G, Hess L, Konsek E, Unkrig C, Walger P, Vetter H, Brackmann HH.

Blood. 2005 Mar 15;105(6):2287-93. Epub 2004 Nov 12.

PMID:
15542586
47.

[24-hour blood pressure and ECG monitoring in patients with arterial hypertonia -- importance of silent myocardial ischemia].

Uen S, Baulmann J, Düsing R, Vetter H, Mengden T.

Dtsch Med Wochenschr. 2004 Nov 12;129(46):2482-5. German. No abstract available.

PMID:
15536582
48.

[Sarcoidosis (Boeck's disease). Inflammatory granulomatous systemic disease which involves especially the lung and lymph nodes].

Pabst S, Vetter H, Grohé Ch.

Praxis (Bern 1994). 2004 Oct 13;93(42):1717-22; quiz 1723-4. Review. German. No abstract available.

PMID:
15529958
49.

Tropisetron inhibits serotonin-induced PGE2 release from macrophage-like synovial cells in serum-free tissue culture.

Seide MF, Ulrich-Merzenich G, Fiebich B, Candelario-Jalil E, Koch FW, Vetter H.

Scand J Rheumatol Suppl. 2004;119:33. No abstract available.

PMID:
15515410
50.

[Bronchiolitis obliterans with organizing pneumonia (BOOP). Influenza simulating illness with opacity spots in the roentgen image (with no response to antibiotics].

Pabst S, Vetter H, Grohé Ch, Wellmann A.

Praxis (Bern 1994). 2004 Sep 15;93(38):1531-6; quiz 1537. German. No abstract available.

PMID:
15495766

Supplemental Content

Loading ...
Support Center